1. Genetic Risk and Chronic Obstructive Pulmonary Disease Independently Predict the Risk of Incident Severe COVID-19
- Author
-
Fen Liang, Xi-Ru Zhang, Wei-jie Guan, Pei-Dong Zhang, Dan Liu, Yujie Zhang, Zhi-Hao Li, Qing-Mei Huang, Wen-Fang Zhong, Shi-gui Yang, Chen Mao, Dong Shen, Jian-Meng Zhou, and Wei-Qi Song
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,viruses ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,severe COVID-19 ,Pulmonary disease ,macromolecular substances ,genetic risk ,Polymorphism, Single Nucleotide ,Pulmonary Disease, Chronic Obstructive ,Risk Factors ,Internal medicine ,medicine ,COPD ,Humans ,Genetic risk ,Original Research ,SARS-CoV-2 ,business.industry ,Genetic variants ,COVID-19 ,virus diseases ,medicine.disease ,Adult Pulmonary ,business - Abstract
Rationale Both genetic variants and chronic obstructive pulmonary disease (COPD) contribute to the risk of incident severe coronavirus disease (COVID-19). Whether genetic risk of incident severe COVID-19 is the same regardless of preexisting COPD is unknown. Objectives In this study, we aimed to investigate the potential interaction between genetic risk and COPD in relation to severe COVID-19. Methods We constructed a polygenic risk score for severe COVID-19 by using 112 single-nucleotide polymorphisms in 430,582 participants from the UK Biobank study. We examined the associations of genetic risk and COPD with severe COVID-19 by using logistic regression models. Results Of 430,582 participants, 712 developed severe COVID-19 as of February 22, 2021, of whom 19.8% had preexisting COPD. Compared with participants at low genetic risk, those at intermediate genetic risk (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.09–1.66) and high genetic risk (OR, 1.50; 95% CI, 1.18–1.92) had higher risk of severe COVID-19 (P for trend = 0.001), and the association was independent of COPD (P for interaction = 0.76). COPD was associated with a higher risk of incident severe COVID-19 (OR, 1.37; 95% CI, 1.12–1.67; P = 0.002). Participants at high genetic risk and with COPD had a higher risk of severe COVID-19 (OR, 2.05; 95% CI, 1.35–3.04; P
- Published
- 2022